Max Robotics — Global Service Robot Directory + US Certification

About

D. Scherr is a leading urologic oncologist whose research focuses on advancing surgical outcomes in bladder cancer treatment, particularly through robotic-assisted techniques. As a key contributor to the International Robotic Cystectomy Consortium, Scherr has helped define early oncologic failure patterns after robot-assisted radical cystectomy, providing critical insights into patient selection and surgical quality. Their landmark study, "PE67: Early oncologic failure after robot-assisted radical cystectomy," has garnered 3 citations and serves as a foundational reference for understanding complications and recurrence risks in minimally invasive bladder cancer surgery. Scherr's work bridges the gap between innovative surgical technology and evidence-based practice, emphasizing the importance of standardized reporting and long-term follow-up in robotic oncology. By systematically analyzing outcomes from multi-institutional data, they have contributed to safer, more effective surgical protocols that directly impact patient survival and quality of life. Scherr remains a respected voice in urologic oncology, dedicated to refining robotic surgical techniques and improving clinical decision-making for bladder cancer patients worldwide.